- Home
- EVAX vs GNS Comparison
EVAX vs GNS Comparison
Compare EVAX & GNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVAX | GNS |
|---|---|---|
| Founded | 2008 | 2002 |
| Country | Denmark | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.7M | 54.4M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | EVAX | GNS |
|---|---|---|
| Price | $5.21 | $0.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.33 | N/A |
| AVG Volume (30 Days) | 89.1K | ★ 863.9K |
| Earning Date | 11-06-2025 | 09-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,650,000.00 | $5,749,894.00 |
| Revenue This Year | $128.77 | $82.78 |
| Revenue Next Year | N/A | $85.90 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 132.17 | N/A |
| 52 Week Low | $1.20 | $0.21 |
| 52 Week High | $12.15 | $1.92 |
Technical Indicators
Market Signals| Indicator | EVAX | GNS |
|---|---|---|
| Relative Strength Index (RSI) | 46.67 | 45.25 |
| Support Level | $4.56 | $0.56 |
| Resistance Level | $5.48 | $0.68 |
| Average True Range (ATR) | 0.43 | 0.04 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 41.18 | 49.80 |
Price Performance
Historical ComparisonAbout EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education, which involves entrepreneur education, management consultancy, and business development tools; and Campus, consisting of resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America. The company derives maximum revenue from Europe/Middle East/Africa.